6505--Bevacizumab Injection
Closed Pre-Solicitation Posted
This opportunity was awarded. See the award notice from , or the latest solicitation from .
- Solicitation number
- 36E79725R0019
- Agency
- National Acquisition Center Headquarters, Department of Veterans Affairs
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Points of contact
-
- Matthew S Poulin matthew.poulin@va.gov (708) 786-5186
Notice details come from SAM.gov. Updated .
About this opportunity
The VA National Acquisition Center intends to issue a Request for Proposal (RFP) 36E79725R0019 for Bevacizumab Injections to support multiple federal healthcare organizations including the Department of Veterans Affairs, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. The procurement is unrestricted and will result in a single contract award to a responsible offeror capable of providing an uninterrupted supply of specified Bevacizumab injection products. Offerors must provide the exact drug name that appears on the label and have a unique NDC number, with their label being the only one affixed to the product. The solicitation will be electronically issued in commercial item format on February 18, 2025, with responses due by March 4, 2025. The point of contact for this procurement is Matthew Poulin, and potential vendors can submit questions via email to Matthew.Poulin@va.gov.
The contract will have a base period of one year with four additional one-year option periods, distributed through VA and DoD Pharmaceutical Prime Vendor Programs. Five different Bevacizumab product variants are eligible, including Avastin, Mvasi, Alymsys, Vegzelma, and Zirabev, with varying annual usage estimates ranging from approximately 4,800 to 23,500 vials across 4mL and 16mL package sizes. The procurement falls under NAICS code 325412 for Pharmaceutical Preparation Manufacturing, with no specific set-aside designations. While specific award values are not detailed, the substantial annual usage suggests a significant contract opportunity for pharmaceutical manufacturers. The contract will be awarded to the offeror demonstrating the most comprehensive and reliable supply capabilities for the specified Bevacizumab injection products.
Notice text
PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue Request for Proposal (RFP) 36E79725R0019 for an unrestricted procurement for Bevacizumab Injections, for the Department of Veterans Affairs (VA) (inclusive of Consolidated Mail Order Pharmacies (CMOPs) and Option 2 State Veterans Homes (SVH)), Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC).
VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA s and DOD s respective Pharmaceutical Prime Vendor Programs.
Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have an NDC number that is unique to the offeror. The successful offeror/contractor's label with its unique NDC shall be the only label on the product. Contractors shall not affix their label over another label on the product.
Solicitation # 36E79725R0019 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about February 18, 2025, with a tentative closing date of March 04, 2025. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at sam.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check Contracting Opportunities at SAM.gov for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Matthew Poulin. Questions can be e-mailed to Matthew.Poulin@va.gov.
The estimated annual requirements are as follows:
REQUIREMENT DESCRIPTION
ITEM
DESCRIPTION
PACKAGE SIZE (VIAL)
TOTAL ESTIMATED ANNUAL USAGE (VIAL)
1a
BEVACIZUMAB 25MG/ML INJ (Trade Name Avastin)
4ML
23,448
1b
BEVACIZUMAB 25MG/ML INJ (Trade Name Avastin)
16ML
13,841
OR
2a
BEVACIZUMAB-AWWB 25MG/ML INJ (Trade Name Mvasi)
4ML
23,212
2b
BEVACIZUMAB-AWWB 25MG/ML INJ (Trade Name Mvasi)
16ML
4,808
OR
3a
BEVACIZUMAB-MALY 25MG/ML INJ (Trade Name Alymsys)
4ML
23,448
3b
BEVACIZUMAB-MALY 25MG/ML INJ (Trade Name Alymsys)
16ML
13,841
OR
4a
BEVACIZUMAB-ADCD 25MG/ML INJ (Trade Name Vegzelma)
4ML
23,448
4b
BEVACIZUMAB-ADCD 25MG/ML INJ (Trade Name Vegzelma)
16ML
13,841
OR
5a
BEVACIZUMAB-BVZR 25MG/ML INJ (Trade Name Zirabev)
4ML
23,448
5b
BEVACIZUMAB-BVZR 25MG/ML INJ (Trade Name Zirabev)
16ML
13,841
Attachments
| File | Type | Posted |
|---|---|---|
| 36E79725R0019_1.docx | DOCX document |
Notice history
| Notice | Type | Posted |
|---|---|---|
| 6505--Bevacizumab Injection Base Year 8/13/2025 - 8/12/2026 | Award Notice | |
| 6505--Bevacizumab Injection | Solicitation | |
| 6505--Bevacizumab Injection | Pre-Solicitation |
On GovTribe
Work this opportunity on GovTribe
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity